11C-preladenant imaging in Parkinson's disease

11C-preladenant imaging in Parkinson's disease - 11C-preladenant imaging in Parkinson's disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038507

Enrollment

Registered

2019-12-01

Start date

2019-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The subjects who were diagnosed with Parkinson's disease. The subjects who can sign the informed consent.

Exclusion criteria

Exclusion criteria: The subjects who cannot undergo MRI. The subject who have chronic dysfunction in the organs. Pregnant or woman who has a chance of pregnant. The subjects who were judged by the clinical investigator to be inappropriate as a participant in this study.

Design outcomes

Primary

Measure	Time frame
To estimate 11C-preladenant bindings	—

Countries

Japan

Contacts

Public ContactKenji Ishibashi

Tokyo Metropolitan Institute of Gerontology Neuroimaging

ishibashi@pet.tmig.or.jp0339643241

Outcome results